Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18403887 | SYSTEM AND METHOD FOR DIGITAL THERAPEUTICS IMPLEMENTING A DIGITAL DEEP LAYER PATIENT PROFILE | January 2024 | November 2025 | Abandon | 23 | 1 | 1 | No | No |
| 18545241 | Fitness Watch Configured with Micro AI | December 2023 | February 2025 | Allow | 14 | 1 | 0 | No | No |
| 18286750 | METHOD, APPARATUS RELATED TO MEDICATION LIST MANAGEMENT, AND COMPUTER-READABLE RECORDING MEDIUM | October 2023 | April 2025 | Abandon | 18 | 1 | 0 | No | No |
| 18552378 | DIAGNOSIS PREDICTION SYSTEM USING DIGITAL DEVICE, LEARNING DEVICE, COMPUTER PROGRAM, DIAGNOSIS PREDICTION METHOD, AND PREDICTION MODEL GENERATION/UPDATING METHOD | September 2023 | September 2025 | Abandon | 24 | 1 | 0 | No | No |
| 18473009 | SYSTEM AND METHOD FOR DETERMINING SUBJECT CONDITIONS IN MOBILE HEALTH CLINICAL TRIALS | September 2023 | January 2025 | Allow | 16 | 1 | 0 | Yes | No |
| 18240474 | Method for Operating a System that Identifies a User's Eating Habits, Recommends Food, and Provides a Food Report | August 2023 | August 2025 | Abandon | 23 | 1 | 0 | No | No |
| 18228662 | STANDARDIZED PATIENT-PROVIDED DATA AND INTERVENTIONS BASED ON SIGNIFICANCE CODES | July 2023 | September 2025 | Abandon | 26 | 0 | 1 | No | No |
| 18356344 | DETERMINING A GENETIC PREDISPOSITION OF A MEDICAL CAUSE | July 2023 | March 2026 | Abandon | 31 | 2 | 0 | Yes | No |
| 17907644 | ANIMAL CARE SUPPORT SYSTEM, ANIMAL CARE SUPPORT SERVER, AND ANIMAL CARE SUPPORT PROGRAM | April 2023 | August 2025 | Abandon | 34 | 1 | 0 | No | No |
| 18090168 | PERSONALIZED THERAPY DELIVERY VIA ASSESSMENT TRACKING | December 2022 | October 2025 | Abandon | 34 | 4 | 0 | Yes | No |
| 17901349 | SYSTEMS AND METHODS FOR PROVIDING DIGITAL HEALTHCARE SERVICES | September 2022 | November 2025 | Abandon | 38 | 2 | 0 | Yes | No |
| 17875819 | SYSTEMS AND METHODS FOR USING MACHINE LEARNING WITH EPIDEMIOLOGICAL MODELING | July 2022 | December 2024 | Abandon | 29 | 1 | 0 | No | No |
| 17845380 | MANAGED MEDICAL INFORMATION EXCHANGE | June 2022 | February 2026 | Allow | 44 | 5 | 0 | No | No |
| 17831772 | MACHINE-LEARNING TECHNIQUES FOR GENERATING ENTITY INSTRUCTIONS | June 2022 | April 2025 | Abandon | 34 | 5 | 1 | Yes | No |
| 17709349 | MACHINE LEARNING DRIVEN AUTOMATED DESIGN OF CLINICAL STUDIES AND ASSESSMENT OF PHARMACEUTICALS AND MEDICAL DEVICES | March 2022 | April 2025 | Abandon | 36 | 1 | 0 | No | No |
| 17695007 | CUSTOMIZED SKIN CARE METHOD AND SYSTEM | March 2022 | August 2025 | Abandon | 41 | 2 | 0 | No | No |
| 17694022 | TEST SERVER, COMMUNICATION TERMINAL, TEST SYSTEM, AND TEST METHOD | March 2022 | October 2024 | Abandon | 32 | 4 | 0 | No | No |
| 17639892 | INFORMATION PRESENTATION DEVICE, LEARNING DEVICE, INFORMATION PRESENTATION METHOD, LEARNING METHOD, INFORMATION PRESENTATION PROGRAM, AND LEARNING PROGRAM | March 2022 | September 2025 | Abandon | 43 | 2 | 0 | No | No |
| 17621837 | SYSTEMS AND METHODS FOR DETERMINING NEONATAL MORTALITY IN ANIMALS | December 2021 | March 2025 | Abandon | 38 | 2 | 0 | Yes | No |
| 17552839 | SYSTEM AND METHOD FOR DETERMINING TESTING AND TREATMENT | December 2021 | May 2025 | Abandon | 41 | 2 | 0 | No | No |
| 17457403 | INGESTING AND PROCESSING CLINICAL INFORMATION BY A CLINICAL ENGINE | December 2021 | January 2025 | Abandon | 37 | 2 | 0 | No | No |
| 17541004 | APPARATUSES, SYSTEMS, AND METHODS FOR DETERMINING HEALTHCARE VITALITY | December 2021 | March 2025 | Abandon | 40 | 2 | 0 | No | No |
| 17531839 | SYSTEM AND METHOD FOR CLINICAL TRIALS | November 2021 | September 2025 | Abandon | 46 | 3 | 0 | Yes | No |
| 17520502 | MEDICAL DEVICE WITH DOSE HELPER FUNCTIONALITY INCLUDING TIME ZONE OR LOCATION DETERMINATION | November 2021 | April 2025 | Allow | 42 | 4 | 0 | Yes | No |
| 17503037 | METHOD AND SYSTEM FOR DYNAMICALLY GENERATING CULTURALLY SENSITIVE PROFILE-SPECIFIC THERAPEUTIC PROTOCOLS USING MACHINE LEARNING MODELS | October 2021 | July 2025 | Abandon | 45 | 1 | 1 | No | No |
| 17469835 | Pan-Indication Gradient Boosting Model Using Tumor Kinetics for Survival Prediction | September 2021 | February 2025 | Abandon | 42 | 2 | 0 | Yes | No |
| 17459998 | TELEHEALTH AND MICRODOSING PLATFORM FOR PSYCHEDELIC-ASSISTED THERAPY | August 2021 | October 2024 | Abandon | 37 | 1 | 0 | No | No |
| 17367420 | MEDICATION RISK EVALUATION METHOD AND MEDICATION RISK EVALUATION DEVICE | July 2021 | October 2025 | Abandon | 52 | 6 | 0 | Yes | No |
| 17335358 | MONITORING A HEALTH CARE PROFESSIONAL MOVEMENT RELATIVE TO A VIRTUAL BOUNDARY IN AN OPERATING ROOM | June 2021 | October 2025 | Abandon | 52 | 4 | 0 | No | No |
| 17335362 | CONTROL ACCESS VERIFICATION OF A HEALTH CARE PROFESSIONAL | June 2021 | October 2025 | Abandon | 53 | 4 | 0 | No | No |
| 17332485 | Adapting Computer Modeling of Infectious Disease Based on Noisy Data | May 2021 | May 2025 | Abandon | 48 | 4 | 0 | No | No |
| 17291401 | Computation Model of Learning Networks | May 2021 | August 2025 | Abandon | 51 | 4 | 0 | Yes | No |
| 17284176 | AUTOMATED TECHNIQUES FOR TESTING PROSPECTIVE MEMORY | April 2021 | April 2025 | Abandon | 48 | 3 | 0 | No | No |
| 17218316 | RECOVERY PROFILE CLUSTERING TO DETERMINE TREATMENT PROTOCOL AND PREDICT RESOURCING NEEDS | March 2021 | October 2025 | Abandon | 55 | 4 | 0 | No | No |
| 17217738 | DEFIBRILLATOR INCIDENT REPORTING AND DEFIBRILLATOR/EPCR INTEGRATION | March 2021 | March 2025 | Allow | 48 | 2 | 1 | Yes | No |
| 17213730 | MEDICAL SYSTEM, NETWORK APPARATUS, MEDICAL APPARATUS, AND INSPECTION INFORMATION PROCESSING METHOD | March 2021 | January 2025 | Abandon | 45 | 2 | 0 | Yes | No |
| 17249819 | UTILIZING MACHINE LEARNING AND NATURAL LANGUAGE PROCESSING TO EXTRACT AND VERIFY VACCINATION DATA | March 2021 | September 2025 | Abandon | 55 | 4 | 0 | Yes | No |
| 17255002 | METHOD FOR DRUG RECOMMENDATION, ELECTRONIC DEVICE AND COMPUTER-READABLE STORAGE MEDIUM | December 2020 | February 2026 | Abandon | 60 | 4 | 0 | No | No |
| 17095299 | METHOD AND A SYSTEM FOR EVALUATING TREATMENT STRATEGIES ON A VIRTUAL MODEL OF A PATIENT | November 2020 | May 2025 | Abandon | 54 | 4 | 0 | No | No |
| 17092431 | METHOD FOR DETERMINING EFFECT FOR AN INDIVIDUAL PATIENT | November 2020 | February 2025 | Abandon | 51 | 3 | 0 | Yes | No |
| 17003736 | SYSTEMS AND METHODS FOR OFFERING PRODUCTS BASED ON MEDICAL ASSESSMENTS | August 2020 | June 2024 | Allow | 46 | 3 | 1 | Yes | No |
| 17001436 | SYSTEMS AND METHODS FOR GENERATING DATA QUALITY INDICES FOR PATIENTS | August 2020 | July 2025 | Abandon | 59 | 6 | 0 | Yes | No |
| 16984118 | SYSTEMS FOR MANAGING BIOPSY SPECIMENS | August 2020 | June 2024 | Allow | 46 | 4 | 0 | Yes | No |
| 16870700 | JOINT GIFT REGISTRY | May 2020 | September 2025 | Abandon | 60 | 2 | 1 | No | Yes |
| 16754399 | ANALYZING CLINICAL PATHWAYS | April 2020 | October 2024 | Abandon | 55 | 6 | 0 | No | No |
| 16652878 | METHODS AND SYSTEMS FOR HEALTHCARE CLINICAL TRIALS | April 2020 | April 2025 | Abandon | 60 | 6 | 0 | No | No |
| 16538115 | PATIENT-BASED DIETARY PLAN RECOMMENDATION SYSTEM | August 2019 | July 2025 | Abandon | 60 | 8 | 0 | Yes | Yes |
| 16466673 | TUMOR TRACKING WITH INTELLIGENT TUMOR SIZE CHANGE NOTICE | June 2019 | September 2025 | Abandon | 60 | 5 | 0 | No | Yes |
| 15319270 | CONTINUOUS MONITORING OF EVENT TRAJECTORIES SYSTEM AND RELATED METHOD | December 2016 | October 2025 | Abandon | 60 | 8 | 0 | No | Yes |
| 15131738 | Healthcare Information System With Clinical Information Exchange | April 2016 | September 2018 | Allow | 29 | 4 | 0 | No | Yes |
| 13933100 | ROUTE NAVIGATION FOR OPTIMAL MOBILE COVERAGE | July 2013 | January 2015 | Allow | 19 | 2 | 0 | Yes | No |
| 12641644 | METHOD AND APPARATUS FOR PROCESSING PHARMACEUTICAL ORDERS TO DETERMINE WHETHER A BUYER OF PHARMACEUTICALS QUALIFIES FOR AN "OWN USE" DISCOUNT | December 2009 | October 2011 | Allow | 22 | 2 | 0 | No | No |
| 12537519 | ONLINE METHOD AND SYSTEM FOR FULFILLING NEEDS RESULTING FROM PROPERTY AND OTHER SIMILAR LOSSES | August 2009 | October 2011 | Allow | 26 | 0 | 0 | Yes | No |
| 12342644 | PROCESS OF INTERFACING A PATIENT INDIRECTLY WITH THEIR OWN ELECTRONIC MEDICAL RECORDS | December 2008 | February 2011 | Allow | 26 | 1 | 0 | Yes | No |
| 11929472 | DISEASE MANAGEMENT SYSTEM AND METHOD INCLUDING PERMISSION DATABASE | October 2007 | December 2013 | Allow | 60 | 4 | 1 | No | No |
| 11769553 | METHOD AND APPARATUS FOR IMPROVING THE LOSS RATIO ON AN INSURANCE PROGRAM BOOK | June 2007 | September 2010 | Allow | 39 | 0 | 0 | No | No |
| 11423881 | METHODS AND APPARATUS FOR INCREASING AND/OR FOR MONITORING A PARTY'S COMPLIANCE WITH A SCHEDULE FOR TAKING MEDICINES | June 2006 | May 2011 | Allow | 59 | 3 | 2 | Yes | No |
| 11444082 | SYSTEM FOR PROVIDING EXPERT CARE TO A BASIC CARE MEDICAL FACILITY FROM A REMOTE LOCATION | May 2006 | September 2009 | Allow | 40 | 0 | 0 | No | No |
| 11315054 | CLIENT DRIVEN HEALTHCARE SYSTEM AND PROCESS | December 2005 | December 2008 | Allow | 36 | 3 | 0 | Yes | No |
| 10939037 | METHOD AND SYSTEM FOR PROVIDING A USER-SELECTED HEALTHCARE SERVICES PACKAGE AND HEALTHCARE SERVICES PANEL CUSTOMIZED BASED ON A USER'S SELECTIONS | September 2004 | March 2009 | Abandon | 55 | 5 | 1 | No | Yes |
| 10922302 | METHOD AND SYSTEM FOR DISPENSING, TRACKING AND MANAGING PHARMACEUTICAL PRODUCTS | August 2004 | March 2010 | Allow | 60 | 1 | 0 | No | No |
| 10808810 | METHOD AND SYSTEM FOR PROVIDING A USER-SELECTED HEALTHCARE SERVICES PACKAGE AND HEALTHCARE SERVICES PANEL CUSTOMIZED BASED ON A USER'S SELECTIONS | March 2004 | June 2010 | Allow | 60 | 3 | 0 | Yes | No |
| 10463125 | METHOD AND SYSTEM FOR INSURING CLUB MEMBERSHIP FEES | June 2003 | December 2009 | Allow | 60 | 4 | 1 | Yes | No |
| 10395400 | PERSONAL BUSINESS SERVICE SYSTEM AND METHOD | March 2003 | April 2013 | Allow | 60 | 8 | 0 | No | Yes |
| 10290725 | SYSTEM AND PROCESS FOR MATCHING PATIENTS WITH CLINICAL MEDICAL TRIALS | November 2002 | April 2008 | Allow | 60 | 3 | 0 | No | No |
| 09941682 | PRESCRIPTION MANAGEMENT SYSTEM | August 2001 | March 2009 | Allow | 60 | 5 | 0 | Yes | No |
| 09865696 | METHOD FOR MONITORING RADIOLOGY MACHINES, OPERATORS AND EXAMINATIONS | May 2001 | September 2010 | Allow | 60 | 6 | 0 | Yes | Yes |
| 09681413 | REINSURANCE AUCTION PROCESS | March 2001 | October 2008 | Allow | 60 | 4 | 1 | Yes | Yes |
| 09798182 | METHODS AND SYSTEMS FOR INSURING AN ENTITY'S EXPOSURE TO LIABILITY | March 2001 | January 2008 | Allow | 60 | 3 | 1 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PORTER, RACHEL L.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 40.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner PORTER, RACHEL L works in Art Unit 3684 and has examined 51 patent applications in our dataset. With an allowance rate of 45.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 52 months.
Examiner PORTER, RACHEL L's allowance rate of 45.1% places them in the 9% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by PORTER, RACHEL L receive 3.45 office actions before reaching final disposition. This places the examiner in the 93% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by PORTER, RACHEL L is 52 months. This places the examiner in the 4% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +29.2% benefit to allowance rate for applications examined by PORTER, RACHEL L. This interview benefit is in the 77% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 14.5% of applications are subsequently allowed. This success rate is in the 10% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 11.1% of cases where such amendments are filed. This entry rate is in the 11% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 20% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 62.5% of appeals filed. This is in the 41% percentile among all examiners. Of these withdrawals, 40.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 38.5% are granted (fully or in part). This grant rate is in the 27% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 21.6% of allowed cases (in the 98% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.